ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Newellis Inc

Newellis Inc (NUWE)

1,25
-0,05
( -3,85% )
Mis à jour : 17:18:03

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
1,25
Prix Achat
1,25
Prix Vente
1,26
Volume échangé
111 720
1,25 Fourchette du Jour 1,32
1,00 Plage de 52 semaines 31,15
Cap du marché
Clôture Veille
1,30
Ouverture
1,30
Dernière Transaction
172
@
1.25
Dernière heure de transaction
17:19:19
Volume financier
US$ 143 005
VWAP
1,28
Volume moyen (3 m)
2 960 270
Actions en circulation
4 373 968
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,02
Bénéfice par action (BPA)
-5,17
Chiffre d'affairess
8,86M
Bénéfice net
-22,63M

À propos de Newellis Inc

Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidne... Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flow, automatically displaying real-time data to the medical staff. Show more

Secteur
Electromedical Apparatus
Industrie
Electromedical Apparatus
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Newellis Inc est coté dans le secteur Electromedical Apparatus de la NASDAQ avec le ticker NUWE. Le dernier cours de clôture d'Newellis était de US$1,30. Au cours de la dernière année, les actions de Newellis ont été négociées dans une fourchette de prix de US$ 1,00 à US$ 31,15.

Newellis compte actuellement 4 373 968 actions en circulation. La capitalisation boursière d'Newellis est de US$5,69 million. Newellis a un ratio cours/bénéfice (ratio PE) de -1.02.

NUWE Dernières nouvelles

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial...

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

MINNEAPOLIS, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company committed to transforming the lives of...

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Reimbursement rate to increase 397% per day effective January 1, 2025 New rate expected to encourage adoption of ultrafiltration therapy in the outpatient setting MINNEAPOLIS, Nov. 04, 2024...

Nuwellis Announces Preliminary Results for Third Quarter of 2024

MINNEAPOLIS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company dedicated to transforming the lives of patients suffering from fluid overload, today...

Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric Customer

MINNEAPOLIS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to...

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

MINNEAPOLIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that...

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to...

New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy

MINNEAPOLIS, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.7-35.89743589741.951.961.23511406041.62860418CS
4-0.56-30.93922651931.814.191.23571341282.5300591CS
12-0.06-4.580152671761.314.19129602702.3581465CS
26-7.5315-85.7655298078.781511.655120710913.5950598CS
52-19.75-94.04761904762131.15126807127.82529173CS
156-5843.75-99.97861420025845647511772160989.42171381CS
260-18499.05-99.993243352818500.318865115346711325.15519796CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
WORXSCWorx Corporation
US$ 1,892
(93,06%)
105,42M
CRNCCerence Inc
US$ 5,17
(83,33%)
32,73M
BDRXBiodexa Pharmaceuticals PLC
US$ 6,13
(59,22%)
3,73M
IBGInnovation Beverage Group Limited
US$ 1,1309
(42,93%)
6,83M
SPAISafe Pro Group Inc
US$ 4,4871
(40,22%)
38,45M
PYXSPyxis Oncology Inc
US$ 2,055
(-46,20%)
9,59M
GLXGGalaxy Payroll Group Ltd
US$ 2,20
(-43,73%)
507,51k
KURAKura Oncology Inc
US$ 9,99
(-37,21%)
7,54M
BLRXBioLineRx Ltd
US$ 0,3571
(-34,50%)
5,72M
SHOTWSafety Shot Inc
US$ 0,1001
(-33,27%)
2,5k
CDTConduit Pharmaceuticals Inc
US$ 0,1109
(20,15%)
490,48M
NVDANVIDIA Corporation
US$ 143,81
(-1,43%)
205,05M
AKTSAkoustis Technologies Inc
US$ 0,1014
(16,42%)
183,54M
ELABElevai Labs Inc
US$ 0,0201
(-6,07%)
150,44M
WORXSCWorx Corporation
US$ 1,892
(93,06%)
105,42M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées